Resource Details

Title

UK national guideline for the management of genital tract infection with Chlamydia trachomatis (2006).

Author(s)Horner PJ; Boag F.
AbstractThis is the current release of the guideline, and it updates a previous version: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002 national guideline for the management of Chlamydia trachomatis genital tract infection. London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD); 2002.

GUIDELINE OBJECTIVE(S):
To reduce the number of sexually transmitted infections and complications of Chlamydia trachomatis genital tract infection
To offer recommendations on the diagnostic tests, treatment regimens, and health promotion principles needed for the effective management of Chlamydia trachomatis

INTERVENTIONS AND PRACTICES CONSIDERED
Diagnosis:
1. Nucleic acid amplification techniques (NAAT)
2. Cell culture (routine use not recommended)
3. Direct fluorescent antibody (DFA) (not recommended routinely)
4. Enzyme immunoassays (EIA) (not recommended routinely)

Treatment/Management
1. Antibiotics including doxycycline, azithromycin, erythromycin, ofloxacin, Deteclo, oxytetracycline, amoxicillin
2. Patient education
3. Partner notification
4. Follow-up, including test of cure in pregnant women or if noncompliance or re-exposure is suspected

MAJOR OUTCOMES CONSIDERED
Sensitivity and specificity of diagnostic tests
Microbiological cure rate
Partner notification rate
Date of publishing02/06/2007
Date of last review by us05/25/2007
Bookmark this page Email this page to a friend Print this page




Review










 





Twitter FeedTwitter Feed